- Home
- SAFE vs MDXG Comparison
SAFE vs MDXG Comparison
Compare SAFE & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFE
- MDXG
- Stock Information
- Founded
- SAFE 2016
- MDXG 2006
- Country
- SAFE United States
- MDXG United States
- Employees
- SAFE N/A
- MDXG N/A
- Industry
- SAFE Real Estate Investment Trusts
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- SAFE Real Estate
- MDXG Health Care
- Exchange
- SAFE Nasdaq
- MDXG Nasdaq
- Market Cap
- SAFE 1.2B
- MDXG 1.0B
- IPO Year
- SAFE 2017
- MDXG N/A
- Fundamental
- Price
- SAFE $15.72
- MDXG $6.77
- Analyst Decision
- SAFE Buy
- MDXG Buy
- Analyst Count
- SAFE 8
- MDXG 1
- Target Price
- SAFE $19.88
- MDXG $12.00
- AVG Volume (30 Days)
- SAFE 294.2K
- MDXG 599.3K
- Earning Date
- SAFE 11-05-2025
- MDXG 10-29-2025
- Dividend Yield
- SAFE 4.56%
- MDXG N/A
- EPS Growth
- SAFE N/A
- MDXG N/A
- EPS
- SAFE 1.43
- MDXG 0.21
- Revenue
- SAFE $393,596,000.00
- MDXG $363,774,000.00
- Revenue This Year
- SAFE $0.58
- MDXG $12.68
- Revenue Next Year
- SAFE $4.98
- MDXG $8.18
- P/E Ratio
- SAFE $10.86
- MDXG $32.03
- Revenue Growth
- SAFE 2.22
- MDXG 6.85
- 52 Week Low
- SAFE $13.43
- MDXG $5.64
- 52 Week High
- SAFE $23.90
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- SAFE 52.74
- MDXG 46.80
- Support Level
- SAFE $15.27
- MDXG $6.58
- Resistance Level
- SAFE $15.82
- MDXG $6.86
- Average True Range (ATR)
- SAFE 0.38
- MDXG 0.20
- MACD
- SAFE 0.07
- MDXG -0.01
- Stochastic Oscillator
- SAFE 86.96
- MDXG 36.17
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.